Hormone receptor positive HER-2 negative breast cancer

Clinical trials for Hormone receptor positive HER-2 negative breast cancer explained in plain language.

Never miss a new study

Get alerted when new Hormone receptor positive HER-2 negative breast cancer trials appear

Sign up with your email to follow new studies for Hormone receptor positive HER-2 negative breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 1

New cancer drug candidate BG-68501 enters first human trials

Disease control Ongoing

This early-phase study tests a new drug called BG-68501 in people with advanced solid tumors that have not responded to standard treatments. The drug targets a protein (CDK2) that helps cancer cells grow. The trial will check safety, find the right dose, and see if the drug shrin…

Matched conditions: HORMONE RECEPTOR POSITIVE HER-2 NEGATIVE BREAST CANCER

Phase 1 • Sponsor: BeiGene • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Hormone receptor positive HER-2 negative breast cancer

Get alerted when new Hormone receptor positive HER-2 negative breast cancer trials appear

New cancer drug candidate BG-68501 enters first human trials